HEADER HYDROLASE 02-MAY-06 2GVF TITLE HCV NS3-4A PROTEASE DOMAIN COMPLEXED WITH A MACROCYCLIC TITLE 2 KETOAMIDE INHIBITOR, SCH419021 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLYPROTEIN; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: NS3 PROTEASE DOMAIN, RESIDUES 1027-1207; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: POLYPROTEIN; COMPND 8 CHAIN: B, D; COMPND 9 FRAGMENT: NS4A PEPTIDE, RESIDUES 1680-1696; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS; SOURCE 3 ORGANISM_TAXID: 11103; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HEPATITIS SOURCE 9 C VIRUS KEYWDS HEPATITIS C, PROTEASE, KETOAMIDE INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR A.ARASAPPAN,F.G.NJOROGE,K.X.CHEN,S.VENKATRAMAN,T.N.PAREKH, AUTHOR 2 H.GU,J.PICHARDO,N.BUTKIEWICZ,A.PRONGAY,V.MADISON, AUTHOR 3 V.GIRIJAVALLABHAN REVDAT 2 24-FEB-09 2GVF 1 VERSN REVDAT 1 23-JAN-07 2GVF 0 JRNL AUTH A.ARASAPPAN,F.G.NJOROGE,K.X.CHEN,S.VENKATRAMAN, JRNL AUTH 2 T.N.PAREKH,H.GU,J.PICHARDO,N.BUTKIEWICZ,A.PRONGAY, JRNL AUTH 3 V.MADISON,V.GIRIJAVALLABHAN JRNL TITL P2-P4 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS JRNL TITL 2 NS3-4A SERINE PROTEASE. JRNL REF BIOORG.MED.CHEM.LETT. V. 16 3960 2006 JRNL REFN ISSN 0960-894X JRNL PMID 16730985 JRNL DOI 10.1016/J.BMCL.2006.05.022 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.L.KIM,K.A.MORGENSTERN,C.LIN,T.FOX,M.DWYER, REMARK 1 AUTH 2 J.A.LANDRO,S.P.CHAMBERS,W.MARKLAND,C.LEPRE, REMARK 1 AUTH 3 E.O'MALLEY REMARK 1 TITL CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS3 REMARK 1 TITL 2 PROTEASE DOMAIN COMPLEXED WITH A SYNTHETIC NS4A REMARK 1 TITL 3 COFACTOR PEPTIDE REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 87 343 1996 REMARK 1 PUBL 8861917 REMARK 1 REFN ISSN 0092-8674 REMARK 1 PMID 8861917 REMARK 1 DOI 10.1016/S0092-8674(00)81351-3 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.YI,X.TONG,A.SKELTON,R.CHASE,T.CHEN,A.PRONGAY, REMARK 1 AUTH 2 S.L.BOGEN,A.K.SAKSENA,F.G.NJOROGE,R.L.VESELENAK, REMARK 1 AUTH 3 R.B.PYLES,N.BOURNE,B.A.MALCOLM,S.M.LEMON REMARK 1 TITL MUTATIONS CONFERRING RESISTANCE TO SCH6, A NOVEL REMARK 1 TITL 2 HEPATITIS C VIRUS NS3/4A PROTEASE INHIBITOR. REMARK 1 TITL 3 REDUCED RNA REPLICATION FITNESS AND PARTIAL RESCUE REMARK 1 TITL 4 BY SECOND-SITE MUTATIONS REMARK 1 REF J.BIOL.CHEM. V. 281 8205 2006 REMARK 1 PUBL 16352601 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 16352601 REMARK 1 DOI 10.1074/JBC.M510246200 REMARK 1 REFERENCE 3 REMARK 1 AUTH Y.LIU,V.S.STOLL,P.L.RICHARDSON,A.SALDIVAR, REMARK 1 AUTH 2 J.L.KLAUS,A.MOLLA,W.KOHLBRENNER,W.M.KATI REMARK 1 TITL HEPATITIS C NS3 PROTEASE INHIBITION BY REMARK 1 TITL 2 PEPTIDYL-ALPHA-KETOAMIDE INHIBITORS: KINETIC REMARK 1 TITL 3 MECHANISM AND STRUCTURE REMARK 1 REF ARCH.BIOCHEM.BIOPHYS. V. 421 207 2004 REMARK 1 PUBL 14984200 REMARK 1 REFN ISSN 0003-9861 REMARK 1 PMID 14984200 REMARK 1 DOI 10.1016/J.ABB.2003.11.013 REMARK 1 REFERENCE 4 REMARK 1 AUTH A.ARASAPPAN,F.G.NJOROGE,T.-Y.CHAN,F.BENNETT, REMARK 1 AUTH 2 S.L.BOGEN,K.CHEN,H.GU,L.HONG,E.JAO,Y.-T.LIU, REMARK 1 AUTH 3 R.G.LOVEY,T.PAREKH,R.E.PIKE,P.PINTO,B.SANTHANAM, REMARK 1 AUTH 4 S.VENKATRAMAN,H.VACCARO,H.WANG,X.YANG,Z.ZHU, REMARK 1 AUTH 5 B.MCKITTRICK,A.K.SAKSENA,V.GIRIJAVALLABHAN, REMARK 1 AUTH 6 J.PICHARDO,N.BUTKIEWICZ,R.INGRAM,B.MALCOLM, REMARK 1 AUTH 7 A.J.PRONGAY,N.YAO,B.MARTEN,V.MADISON,S.KEMP,O.LEVY, REMARK 1 AUTH 8 M.LIM-WILBY,S.TAMURA,A.K.GANGULY REMARK 1 TITL HEPATITIS C VIRUS NS3-4A SERINE PROTEASE REMARK 1 TITL 2 INHIBITORS: SAR OF P'2 MOIETY WITH IMPROVED POTENCY REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 15 4180 2005 REMARK 1 PUBL 16087332 REMARK 1 REFN ISSN 0960-894X REMARK 1 PMID 16087332 REMARK 1 DOI 10.1016/J.BMCL.2005.06.091 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 98.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 22899 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2252 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.61 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2249 REMARK 3 BIN R VALUE (WORKING SET) : 0.3480 REMARK 3 BIN FREE R VALUE : 0.3523 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 254 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2748 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 59 REMARK 3 SOLVENT ATOMS : 128 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.24 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.82 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : 1.36 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2GVF COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-MAY-06. REMARK 100 THE RCSB ID CODE IS RCSB037595. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 95.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : ADSC, DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25194 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.560 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07300 REMARK 200 FOR THE DATA SET : 22.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.54700 REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION MIXED WITH EQUAL REMARK 280 VOLUME OF A SOLUTION CONTAINING 0.75-1.00 M NACL, 0.1 M MES, REMARK 280 0.1 M NA/K PO4, PH 5.6-6.2. THE TRAYS WERE SET AT 277K FOR 5-7 REMARK 280 DAYS TO CONTROL NUCLEATION, FOLLOWED BY INCUBATION FOR 3 WEEKS REMARK 280 AT 285 K TO MAXIMIZE CRYSTAL GROWTH, PH 5.6-5.8, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z REMARK 290 6555 -X,-X+Y,-Z REMARK 290 7555 X+2/3,Y+1/3,Z+1/3 REMARK 290 8555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 9555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 10555 Y+2/3,X+1/3,-Z+1/3 REMARK 290 11555 X-Y+2/3,-Y+1/3,-Z+1/3 REMARK 290 12555 -X+2/3,-X+Y+1/3,-Z+1/3 REMARK 290 13555 X+1/3,Y+2/3,Z+2/3 REMARK 290 14555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 15555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 16555 Y+1/3,X+2/3,-Z+2/3 REMARK 290 17555 X-Y+1/3,-Y+2/3,-Z+2/3 REMARK 290 18555 -X+1/3,-X+Y+2/3,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 112.30750 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 64.84077 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 25.10700 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 112.30750 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 64.84077 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 25.10700 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 112.30750 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 64.84077 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 25.10700 REMARK 290 SMTRY1 10 -0.500000 0.866025 0.000000 112.30750 REMARK 290 SMTRY2 10 0.866025 0.500000 0.000000 64.84077 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 25.10700 REMARK 290 SMTRY1 11 1.000000 0.000000 0.000000 112.30750 REMARK 290 SMTRY2 11 0.000000 -1.000000 0.000000 64.84077 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 25.10700 REMARK 290 SMTRY1 12 -0.500000 -0.866025 0.000000 112.30750 REMARK 290 SMTRY2 12 -0.866025 0.500000 0.000000 64.84077 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 25.10700 REMARK 290 SMTRY1 13 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 129.68153 REMARK 290 SMTRY3 13 0.000000 0.000000 1.000000 50.21400 REMARK 290 SMTRY1 14 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 14 0.866025 -0.500000 0.000000 129.68153 REMARK 290 SMTRY3 14 0.000000 0.000000 1.000000 50.21400 REMARK 290 SMTRY1 15 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 15 -0.866025 -0.500000 0.000000 129.68153 REMARK 290 SMTRY3 15 0.000000 0.000000 1.000000 50.21400 REMARK 290 SMTRY1 16 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 16 0.866025 0.500000 0.000000 129.68153 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 50.21400 REMARK 290 SMTRY1 17 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 17 0.000000 -1.000000 0.000000 129.68153 REMARK 290 SMTRY3 17 0.000000 0.000000 -1.000000 50.21400 REMARK 290 SMTRY1 18 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 18 -0.866025 0.500000 0.000000 129.68153 REMARK 290 SMTRY3 18 0.000000 0.000000 -1.000000 50.21400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS A DIMER OF THE NS3 PROTEASE REMARK 300 DOMAIN, WITH EACH MONOMER COMPLEXED WITH A MOLECULE OF THE NS4A REMARK 300 PEPTIDE. BOTH MONOMERS OF THE NS3-4A COMPLEX HAVE A STRUCTURALLY REMARK 300 BOUND ZINC ATOM. THE CHAIN A MONOMER OF THE NS3-4A COMPLEX HAS A REMARK 300 COVALENTLY BOUND KETOAMIDE, WITH A LINKAGE BETWEEN SER139 OG AND REMARK 300 C38 OF THE KETOAMIDE. THE NS3 PROTEASE DOMAIN IS PART OF THE REMARK 300 LARGER NS3 PROTEASE-HELICASE PROTEIN THAT IS CATALYTICALLY REMARK 300 ACTIVE WHEN COMPLEXED WITH THE NS4A PROTEIN. THE NS3 PROTEASE REMARK 300 DOMAIN-NS4A PEPTIDE COMPLEX IS CATALYTICALLY ACTIVE, BUT THIS IS REMARK 300 NOT THE BIOLOGICALLY ACTIVE FORM. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -57.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -45.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -125.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A -9 REMARK 465 SER A -8 REMARK 465 MET A -7 REMARK 465 THR A -6 REMARK 465 GLY A -5 REMARK 465 GLY A -4 REMARK 465 GLN A -3 REMARK 465 GLN A -2 REMARK 465 GLY A 182 REMARK 465 SER A 183 REMARK 465 HIS A 184 REMARK 465 HIS A 185 REMARK 465 HIS A 186 REMARK 465 HIS A 187 REMARK 465 HIS A 188 REMARK 465 HIS A 189 REMARK 465 LYS B 19 REMARK 465 ALA C -9 REMARK 465 SER C -8 REMARK 465 MET C -7 REMARK 465 THR C -6 REMARK 465 GLY C -5 REMARK 465 GLY C -4 REMARK 465 GLN C -3 REMARK 465 GLN C -2 REMARK 465 MET C -1 REMARK 465 GLY C 0 REMARK 465 ALA C 1 REMARK 465 PRO C 2 REMARK 465 ILE C 3 REMARK 465 THR C 4 REMARK 465 ALA C 5 REMARK 465 TYR C 6 REMARK 465 ALA C 7 REMARK 465 GLN C 8 REMARK 465 GLN C 9 REMARK 465 THR C 10 REMARK 465 ARG C 11 REMARK 465 GLY C 12 REMARK 465 LEU C 13 REMARK 465 LEU C 14 REMARK 465 GLY C 15 REMARK 465 CYS C 16 REMARK 465 ILE C 17 REMARK 465 ILE C 18 REMARK 465 THR C 19 REMARK 465 SER C 20 REMARK 465 LEU C 21 REMARK 465 THR C 22 REMARK 465 GLY C 23 REMARK 465 ARG C 24 REMARK 465 ASP C 25 REMARK 465 LYS C 26 REMARK 465 ASN C 27 REMARK 465 ARG C 180 REMARK 465 SER C 181 REMARK 465 GLY C 182 REMARK 465 SER C 183 REMARK 465 HIS C 184 REMARK 465 HIS C 185 REMARK 465 HIS C 186 REMARK 465 HIS C 187 REMARK 465 HIS C 188 REMARK 465 HIS C 189 REMARK 465 LYS D 19 REMARK 465 LYS D 20 REMARK 465 ILE D 37 REMARK 465 ILE D 38 REMARK 465 PRO D 39 REMARK 465 LYS D 40 REMARK 465 LYS D 41 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 2 C - N - CA ANGL. DEV. = -9.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 1 -112.30 -39.97 REMARK 500 THR A 38 -166.84 -108.33 REMARK 500 PHE A 43 -159.01 -148.09 REMARK 500 ASP A 81 38.50 70.02 REMARK 500 CYS A 99 1.81 -162.15 REMARK 500 ALA A 111 33.39 71.25 REMARK 500 ASP A 121 -46.72 66.79 REMARK 500 PRO A 146 -16.88 -43.79 REMARK 500 PHE C 154 109.10 -54.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 105 0.06 SIDE_CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 901 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 97 SG REMARK 620 2 CYS A 145 SG 97.6 REMARK 620 3 HOH A1013 O 117.9 120.3 REMARK 620 4 CYS A 99 SG 92.7 115.2 109.6 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN C 902 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS C 99 SG REMARK 620 2 CYS C 145 SG 114.1 REMARK 620 3 HOH C 903 O 106.6 123.3 REMARK 620 4 CYS C 97 SG 100.1 99.2 110.9 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 901 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN C 902 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NHN A 999 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A1R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS3 PROTEASE REMARK 900 DOMAIN COMPLEXED WITH A SYNTHETIC NS4A COFACTOR PEPTIDE REMARK 900 RELATED ID: 2FM2 RELATED DB: PDB REMARK 900 HCV NS3-4A PROTEASE DOMAIN COMPLEXED WITH A KETOAMIDE REMARK 900 INHIBITOR, SCH446211 REMARK 900 RELATED ID: 1RGQ RELATED DB: PDB REMARK 900 M9A HCV PROTEASE COMPLEX WITH PENTAPEPTIDE KETO-AMIDE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2A4G RELATED DB: PDB REMARK 900 HEPATITIS C PROTEASE NS3-4A SERINE PROTEASE WITH KETOAMIDE REMARK 900 INHIBITOR SCH225724 BOUND REMARK 900 RELATED ID: 2A4R RELATED DB: PDB REMARK 900 HCV NS3 PROTEASE DOMAIN WITH A KETOAMIDE INHIBITOR REMARK 900 COVALENTLY BOUND REMARK 900 RELATED ID: 2A4Q RELATED DB: PDB REMARK 900 HCV NS3 PROTEASE WITH NS4A PEPTIDE AND A COVALENTLY BOUND REMARK 900 MACROCYCLIC KETOAMIDE COMPOUND DBREF 2GVF A 1 181 GB 22129793 NP_671491 1027 1207 DBREF 2GVF C 1 181 GB 22129793 NP_671491 1027 1207 DBREF 2GVF B 23 39 GB 22129793 NP_671491 1680 1696 DBREF 2GVF D 23 39 GB 22129793 NP_671491 1680 1696 SEQADV 2GVF ALA A -9 GB 22129793 CLONING ARTIFACT SEQADV 2GVF SER A -8 GB 22129793 CLONING ARTIFACT SEQADV 2GVF MET A -7 GB 22129793 CLONING ARTIFACT SEQADV 2GVF THR A -6 GB 22129793 CLONING ARTIFACT SEQADV 2GVF GLY A -5 GB 22129793 CLONING ARTIFACT SEQADV 2GVF GLY A -4 GB 22129793 CLONING ARTIFACT SEQADV 2GVF GLN A -3 GB 22129793 CLONING ARTIFACT SEQADV 2GVF GLN A -2 GB 22129793 CLONING ARTIFACT SEQADV 2GVF MET A -1 GB 22129793 CLONING ARTIFACT SEQADV 2GVF GLY A 0 GB 22129793 CLONING ARTIFACT SEQADV 2GVF GLY A 182 GB 22129793 CLONING ARTIFACT SEQADV 2GVF SER A 183 GB 22129793 CLONING ARTIFACT SEQADV 2GVF HIS A 184 GB 22129793 EXPRESSION TAG SEQADV 2GVF HIS A 185 GB 22129793 EXPRESSION TAG SEQADV 2GVF HIS A 186 GB 22129793 EXPRESSION TAG SEQADV 2GVF HIS A 187 GB 22129793 EXPRESSION TAG SEQADV 2GVF HIS A 188 GB 22129793 EXPRESSION TAG SEQADV 2GVF HIS A 189 GB 22129793 EXPRESSION TAG SEQADV 2GVF ALA C -9 GB 22129793 CLONING ARTIFACT SEQADV 2GVF SER C -8 GB 22129793 CLONING ARTIFACT SEQADV 2GVF MET C -7 GB 22129793 CLONING ARTIFACT SEQADV 2GVF THR C -6 GB 22129793 CLONING ARTIFACT SEQADV 2GVF GLY C -5 GB 22129793 CLONING ARTIFACT SEQADV 2GVF GLY C -4 GB 22129793 CLONING ARTIFACT SEQADV 2GVF GLN C -3 GB 22129793 CLONING ARTIFACT SEQADV 2GVF GLN C -2 GB 22129793 CLONING ARTIFACT SEQADV 2GVF MET C -1 GB 22129793 CLONING ARTIFACT SEQADV 2GVF GLY C 0 GB 22129793 CLONING ARTIFACT SEQADV 2GVF GLY C 182 GB 22129793 CLONING ARTIFACT SEQADV 2GVF SER C 183 GB 22129793 CLONING ARTIFACT SEQADV 2GVF HIS C 184 GB 22129793 EXPRESSION TAG SEQADV 2GVF HIS C 185 GB 22129793 EXPRESSION TAG SEQADV 2GVF HIS C 186 GB 22129793 EXPRESSION TAG SEQADV 2GVF HIS C 187 GB 22129793 EXPRESSION TAG SEQADV 2GVF HIS C 188 GB 22129793 EXPRESSION TAG SEQADV 2GVF HIS C 189 GB 22129793 EXPRESSION TAG SEQADV 2GVF LYS B 19 GB 22129793 INSERTION SEQADV 2GVF LYS B 20 GB 22129793 INSERTION SEQADV 2GVF GLY B 21 GB 22129793 INSERTION SEQADV 2GVF SER B 22 GB 22129793 INSERTION SEQADV 2GVF LYS B 40 GB 22129793 INSERTION SEQADV 2GVF LYS B 41 GB 22129793 INSERTION SEQADV 2GVF LYS D 19 GB 22129793 INSERTION SEQADV 2GVF LYS D 20 GB 22129793 INSERTION SEQADV 2GVF GLY D 21 GB 22129793 INSERTION SEQADV 2GVF SER D 22 GB 22129793 INSERTION SEQADV 2GVF LYS D 40 GB 22129793 INSERTION SEQADV 2GVF LYS D 41 GB 22129793 INSERTION SEQRES 1 A 199 ALA SER MET THR GLY GLY GLN GLN MET GLY ALA PRO ILE SEQRES 2 A 199 THR ALA TYR ALA GLN GLN THR ARG GLY LEU LEU GLY CYS SEQRES 3 A 199 ILE ILE THR SER LEU THR GLY ARG ASP LYS ASN GLN VAL SEQRES 4 A 199 GLU GLY GLU VAL GLN ILE VAL SER THR ALA THR GLN THR SEQRES 5 A 199 PHE LEU ALA THR CYS ILE ASN GLY VAL CYS TRP THR VAL SEQRES 6 A 199 TYR HIS GLY ALA GLY THR ARG THR ILE ALA SER PRO LYS SEQRES 7 A 199 GLY PRO VAL ILE GLN MET TYR THR ASN VAL ASP GLN ASP SEQRES 8 A 199 LEU VAL GLY TRP PRO ALA PRO GLN GLY SER ARG SER LEU SEQRES 9 A 199 THR PRO CYS THR CYS GLY SER SER ASP LEU TYR LEU VAL SEQRES 10 A 199 THR ARG HIS ALA ASP VAL ILE PRO VAL ARG ARG ARG GLY SEQRES 11 A 199 ASP SER ARG GLY SER LEU LEU SER PRO ARG PRO ILE SER SEQRES 12 A 199 TYR LEU LYS GLY SER SER GLY GLY PRO LEU LEU CYS PRO SEQRES 13 A 199 ALA GLY HIS ALA VAL GLY LEU PHE ARG ALA ALA VAL CYS SEQRES 14 A 199 THR ARG GLY VAL ALA LYS ALA VAL ASP PHE ILE PRO VAL SEQRES 15 A 199 GLU ASN LEU GLU THR THR MET ARG SER GLY SER HIS HIS SEQRES 16 A 199 HIS HIS HIS HIS SEQRES 1 B 23 LYS LYS GLY SER VAL VAL ILE VAL GLY ARG ILE VAL LEU SEQRES 2 B 23 SER GLY LYS PRO ALA ILE ILE PRO LYS LYS SEQRES 1 C 199 ALA SER MET THR GLY GLY GLN GLN MET GLY ALA PRO ILE SEQRES 2 C 199 THR ALA TYR ALA GLN GLN THR ARG GLY LEU LEU GLY CYS SEQRES 3 C 199 ILE ILE THR SER LEU THR GLY ARG ASP LYS ASN GLN VAL SEQRES 4 C 199 GLU GLY GLU VAL GLN ILE VAL SER THR ALA THR GLN THR SEQRES 5 C 199 PHE LEU ALA THR CYS ILE ASN GLY VAL CYS TRP THR VAL SEQRES 6 C 199 TYR HIS GLY ALA GLY THR ARG THR ILE ALA SER PRO LYS SEQRES 7 C 199 GLY PRO VAL ILE GLN MET TYR THR ASN VAL ASP GLN ASP SEQRES 8 C 199 LEU VAL GLY TRP PRO ALA PRO GLN GLY SER ARG SER LEU SEQRES 9 C 199 THR PRO CYS THR CYS GLY SER SER ASP LEU TYR LEU VAL SEQRES 10 C 199 THR ARG HIS ALA ASP VAL ILE PRO VAL ARG ARG ARG GLY SEQRES 11 C 199 ASP SER ARG GLY SER LEU LEU SER PRO ARG PRO ILE SER SEQRES 12 C 199 TYR LEU LYS GLY SER SER GLY GLY PRO LEU LEU CYS PRO SEQRES 13 C 199 ALA GLY HIS ALA VAL GLY LEU PHE ARG ALA ALA VAL CYS SEQRES 14 C 199 THR ARG GLY VAL ALA LYS ALA VAL ASP PHE ILE PRO VAL SEQRES 15 C 199 GLU ASN LEU GLU THR THR MET ARG SER GLY SER HIS HIS SEQRES 16 C 199 HIS HIS HIS HIS SEQRES 1 D 23 LYS LYS GLY SER VAL VAL ILE VAL GLY ARG ILE VAL LEU SEQRES 2 D 23 SER GLY LYS PRO ALA ILE ILE PRO LYS LYS HET ZN A 901 1 HET ZN C 902 1 HET NHN A 999 57 HETNAM ZN ZINC ION HETNAM NHN (6R,8S,11S)-11-CYCLOHEXYL-N-(1-{[(2-{[(1S)-2- HETNAM 2 NHN (DIMETHYLAMINO)-2-OXO-1-PHENYLETHYL]AMINO}-2- HETNAM 3 NHN OXOETHYL)AMINO](OXO)ACETYL}BUTYL)-10,13-DIOXO-2,5- HETNAM 4 NHN DIOXA-9,12-DIAZATRICYCLO[14.3.1.1~6,9~]HENICOSA-1(20), HETNAM 5 NHN 16,18-TRIENE-8-CARBOXAMIDE FORMUL 5 ZN 2(ZN 2+) FORMUL 7 NHN C42 H56 N6 O9 FORMUL 8 HOH *128(H2 O) HELIX 1 1 GLY A 12 GLY A 23 1 12 HELIX 2 2 TYR A 56 GLY A 60 1 5 HELIX 3 3 ILE A 132 LYS A 136 1 5 HELIX 4 4 VAL A 172 SER A 181 1 10 HELIX 5 5 TYR C 56 GLY C 60 1 5 HELIX 6 6 ILE C 132 LYS C 136 1 5 HELIX 7 7 VAL C 172 MET C 179 1 8 SHEET 1 A 7 TYR A 6 GLN A 9 0 SHEET 2 A 7 VAL B 24 VAL B 30 -1 O VAL B 30 N TYR A 6 SHEET 3 A 7 VAL A 33 SER A 37 -1 N ILE A 35 O VAL B 26 SHEET 4 A 7 THR A 42 ILE A 48 -1 O ALA A 45 N GLN A 34 SHEET 5 A 7 VAL A 51 VAL A 55 -1 O TRP A 53 N THR A 46 SHEET 6 A 7 LEU A 82 PRO A 86 -1 O TRP A 85 N CYS A 52 SHEET 7 A 7 TYR A 75 ASN A 77 -1 N ASN A 77 O LEU A 82 SHEET 1 B 2 ILE A 64 SER A 66 0 SHEET 2 B 2 GLY A 69 VAL A 71 -1 O VAL A 71 N ILE A 64 SHEET 1 C 7 ASP A 103 VAL A 107 0 SHEET 2 C 7 VAL A 113 ARG A 118 -1 O ILE A 114 N LEU A 106 SHEET 3 C 7 ARG A 123 PRO A 131 -1 O SER A 125 N ARG A 117 SHEET 4 C 7 VAL A 163 PRO A 171 -1 O LYS A 165 N LEU A 126 SHEET 5 C 7 HIS A 149 THR A 160 -1 N ALA A 156 O ASP A 168 SHEET 6 C 7 PRO A 142 CYS A 145 -1 N LEU A 143 O VAL A 151 SHEET 7 C 7 ASP A 103 VAL A 107 -1 N TYR A 105 O LEU A 144 SHEET 1 D 3 ALA B 36 ILE B 37 0 SHEET 2 D 3 SER D 22 VAL D 30 -1 O VAL D 30 N ALA B 36 SHEET 3 D 3 THR C 63 ILE C 64 1 N THR C 63 O VAL D 23 SHEET 1 E 7 ALA B 36 ILE B 37 0 SHEET 2 E 7 SER D 22 VAL D 30 -1 O VAL D 30 N ALA B 36 SHEET 3 E 7 VAL C 33 SER C 37 -1 N ILE C 35 O VAL D 26 SHEET 4 E 7 THR C 42 ILE C 48 -1 O PHE C 43 N VAL C 36 SHEET 5 E 7 VAL C 51 VAL C 55 -1 O VAL C 51 N ILE C 48 SHEET 6 E 7 LEU C 82 PRO C 86 -1 O TRP C 85 N CYS C 52 SHEET 7 E 7 TYR C 75 ASN C 77 -1 N TYR C 75 O GLY C 84 SHEET 1 F 7 ASP C 103 VAL C 107 0 SHEET 2 F 7 VAL C 113 GLY C 120 -1 O ILE C 114 N LEU C 106 SHEET 3 F 7 ARG C 123 PRO C 131 -1 O SER C 125 N ARG C 117 SHEET 4 F 7 VAL C 163 PRO C 171 -1 O ALA C 164 N ARG C 130 SHEET 5 F 7 ALA C 150 CYS C 159 -1 N ALA C 156 O ASP C 168 SHEET 6 F 7 PRO C 142 LEU C 144 -1 N LEU C 143 O VAL C 151 SHEET 7 F 7 ASP C 103 VAL C 107 -1 N TYR C 105 O LEU C 144 LINK OG SER A 139 C38 NHN A 999 1555 1555 1.41 LINK ZN ZN A 901 SG CYS A 97 1555 1555 2.03 LINK ZN ZN A 901 SG CYS A 145 1555 1555 2.27 LINK ZN ZN A 901 O HOH A1013 1555 1555 1.53 LINK ZN ZN A 901 SG CYS A 99 1555 1555 2.39 LINK ZN ZN C 902 SG CYS C 99 1555 1555 2.16 LINK ZN ZN C 902 SG CYS C 145 1555 1555 2.14 LINK ZN ZN C 902 O HOH C 903 1555 1555 2.18 LINK ZN ZN C 902 SG CYS C 97 1555 1555 2.10 SITE 1 AC1 5 CYS A 97 THR A 98 CYS A 99 CYS A 145 SITE 2 AC1 5 HOH A1013 SITE 1 AC2 4 CYS C 97 CYS C 99 CYS C 145 HOH C 903 SITE 1 AC3 14 GLN A 41 THR A 42 HIS A 57 ILE A 132 SITE 2 AC3 14 LYS A 136 GLY A 137 SER A 138 SER A 139 SITE 3 AC3 14 ARG A 155 ALA A 156 ALA A 157 CYS A 159 SITE 4 AC3 14 ASP A 168 HOH A1016 CRYST1 224.615 224.615 75.321 90.00 90.00 120.00 H 3 2 36 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004452 0.002570 0.000000 0.00000 SCALE2 0.000000 0.005141 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013277 0.00000